Professor Song Guangyuan from Beijing Anzhen Hospital Capital Medical University, presented one-year follow-up data from the TaurusTrio ALTER-AR study, titled "ALTER Study Results and Preliminary Chinese Single-Center Experience Treating Extra-Large Aortic Valve Annuli.
T h e A L T E R - A R s t u d y demonstrated a technical succes s rate of 99.1%, surpassing the ALIGN-AR results. This highlights both the procedural stability of TaurusTrio in treating aortic regurgitation anatomy and the growing expertise ofChinese operators. Furthermore, the system confirmed its safety profile, hemodynamic performance, and anatomical adaptability in challenging cases including extra-large annuli, dilated ascending aorta, and horizontal heart orientation.
